Amneal stock: buy or sell?
January 17th, 2020
Should I buy Amneal stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. That's why is so important to define your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Amneal stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Amneal Pharmaceuticals stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we gathered 15 ratings published for AMRX stock in the last month. The general sentiment of these ratings is bullish for AMRX stock, with 8 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-6||BMO Capital Markets||n/a||Market Perform|
|2019-7-8||Piper Jaffray Companies||Neutral||Overweight|
|2019-7-22||Svb Leerink||Market Perform||Outperform|
|2019-7-11||Royal Bank of Canada||Outperform||Sector Perform|
|2019-5-21||Raymond James||Market Perform||Strong-Buy|
|2019-3-8||Svb Leerink||Outperform||Market Perform|
|2019-3-8||Leerink Swann||n/a||Market Perform|
Amneal stock analysis
Shares of Amneal Pharmaceuticals ended yesterday at $5.10 and plunged a hair-raising -4.67%.
Amneal Pharmaceuticals ended yesterday at $5.10 and plunged a hair-raising -4.67%. Since SMA50d and SMA100d crossed up on December, AMRX price climbed $1.06 per share (26.24%). Since November when AMRX stock price broke up the SMA100d line, it gained $2.06 (67.76%).
Amneal Pharmaceuticals shares skyrocketed 13.08% this week, ending at $5.10. Late December 2019 AMRX plummed a frightening -7.32% in just one week.
Amneal stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Since mid November 2019 when AMRX stock price broke up the SMA20w line, it gained $2.35 (85.45%).
Amneal stock price history
Amneal IPO was on May 7th, 2018 at $17.00 per share1. Since then, AMRX stock lost a -70.00%, with a yearly average of -70.00%.
1: Adjusted price after possible price splits or reverse-splits.
Amneal stock historical price chart
AMRX stock reached 52-week highs on March at $14.79, and all-time highs 2018-08-22 with a price of 24.48.
Amneal stock price target is $8.30Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we found 11 price targets for Amneal stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-6||BMO Capital Markets||Lowers Target||$6.00||$5.00||-16.7%|
|2019-7-8||Piper Jaffray Companies||Upgrades||n/a||$11.00||-|
|2019-7-11||Royal Bank of Canada||Downgrades||$11.00||$6.00||-45.5%|
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter posting its last earnings report on May, Amneal Pharmaceuticals . As soon as we get its posted EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Amneal annual revenues skyrocketed a dazzling 60.89% to $1,662.99 million dollars from $1,033.65 marked in 2017. In contrary, its earnings margin (compared to revenues) decreased to -1.26%, that is $-20.92 million. Amneal Pharmaceuticals fiscal year ends in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Amneal Pharmaceuticals TTM sales up to were $1,387.80 and income $-20.92 million dollars. When comparing this TTM figures with the last reported annuality, we can esteem Amneal Pharmaceuticals business evolution since December 2018: Annual turnover up to , compared to lastest yearly report, plummed a spooky -16.55%. Regarding profit margin, Amneal Pharmaceuticals stayed stable -0.25% to -1.26%
|2013||$512 M||-||$101 M19.8%||-|
|2014||$596 M||16.53%||$57 M9.6%||-43.36%|
|2015||$860 M||44.36%||$39 M4.5%||-32.00%|
|2016||$1,018 M||18.33%||$0.00 M0.0%||-100.00%|
|2017||$1,034 M||1.52%||$0.00 M0.0%||0.00%|
|2018||$1,663 M||60.89%||$-20.92 M-1.3%||0.00%|
|TTM||$1,388 M||-16.55%||$-20.92 M-1.5%||0.00%|
Quarterly financial resultsAmneal Pharmaceuticals reported M in revenues for 2019-Q1, a -100.00% less compared to previous quarter. Reported quarter income marked M with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was -1.76%. When comparing sales to same quarter last year, Amneal sales marked a tight movement and remained steady a nan%.
|2017-Q1||$184 M||-||$-98.43 M-53.4%||-|
|2017-Q2||$260 M||40.93%||$37.45 M14.4%||-138.04%|
|2017-Q3||$255 M||-1.98%||$0.00 M0.0%||-100.00%|
|2017-Q4||$183 M||-28.20%||$-301.07 M-164.6%||0.00%|
|2018-Q2||$414 M||126.22%||$-19.10 M-4.6%||-93.65%|
|2018-Q3||$476 M||15.15%||$6.95 M1.5%||-136.39%|
|2018-Q4||$498 M||4.42%||$-8.77 M-1.8%||-226.12%|
Amneal ownershipWhen you are planning to invest in shares of a company, it's always worth to check its ownership structure.
Amneal shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 13.06% of all shares.
In case of Amneal stock, 76.70% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AMRX stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$683.9 M|
|Total shares||134.1 M|
|Float shares||82.3 M|
|- Institutional holdings (%)||76.7%|
|- Insider holdings (%)||13.1%|
|Shares in short selling||0.0%|
|Friday, January 17th, 2020|
|Day range||$5.02 - $5.44|
|Average true range||$0.33|
|50d mov avg||$4.01|
|100d mov avg||$3.53|
|200d mov avg||$5.53|
Amneal performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. For Amneal Pharmaceuticals, the comparison is made against .